Management of Bleeding and Coagulopathy After Heart Surgery

This publication has 25 references indexed in Scilit:

• Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment
  The American Journal of Cardiology, 1999
• Reexploration for Hemorrhage Following Coronary Artery Bypass GraftingIncidence and Risk Factors
  Archives of Surgery, 1998
• Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximab
  The Journal of Thoracic and Cardiovascular Surgery, 1998
• Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty
  Circulation, 1997
• Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
  New England Journal of Medicine, 1997
• Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
  The Lancet, 1997
• Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
  The Lancet, 1997
• Intravenous vitamin K1prior to orthotopic heart transplantation: effectsin vivoandin vitro
  Acta Anaesthesiologica Scandinavica, 1997
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency
  The Journal of Thoracic and Cardiovascular Surgery, 1994